Collaborators GCD. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in;195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (vol 392, pg 1736, 2018). Lancet. 2018;392(10160):2170.
Fuchs A, Kuhl JT, Sigvardsen PE, Afzal S, Knudsen AD, Moller MB, et al. Subclinical coronary atherosclerosis and risk for myocardial infarction in a danish cohort : a prospective observational cohort study. Ann Intern Med. 2023;176(4):433–42.
Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129–46.
Rajaobelina K, Helmer C, Velayoudom-Cephise FL, Nov S, Farges B, Pupier E, et al. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes. Diabetes Metab Res Rev. 2017. https://doi.org/10.1002/dmrr.2917.
Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R. Reference values of skin autofluorescence. Diabetes Technol The. 2010;12(5):399–403.
Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, et al. Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML). Cardiovasc Diabetol. 2009;8:45.
Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, et al. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis. 1998;141(1):61–75.
Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, et al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol. 1993;143(6):1649–56.
Sabbatinelli J, Castiglione S, Macri F, Giuliani A, Ramini D, Vinci MC, et al. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):95.
Majchrzak C, Cougnard-Gregoire A, Le-Goff M, Feart C, Delcourt C, Reydit M, et al. Skin autofluorescence of advanced glycation end-products and mortality in older adults: the roles of chronic kidney disease and diabetes. Nutr Metab Cardiovasc Dis. 2022;32(11):2526–33.
Martinez-Sanchez FD, Medina-Urrutia AX, Jorge-Galarza E, Martinez-Alvarado MDR, Reyes-Barrera J, Osorio-Alonso H, et al. Effect of metabolic control on recurrent major adverse cardiovascular events and cardiovascular mortality in patients with premature coronary artery disease: results of the Genetics of Atherosclerotic Disease study. Nutr Metab Cardiovasc Dis. 2022;32(9):2227–37.
Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, et al. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovasc Diabetol. 2015;14:118.
Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348(23):2294–303.
Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT skin collagen ancillary study group. diabetes control and complications trial. Diabetes. 1999;48(4):870–80.
Borderie G, Foussard N, Larroumet A, Blanco L, Barbet-Massin MA, Ducos C, et al. The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: a longitudinal observational study. J Diabetes Complicat. 2023;37(10):108595.
Cavero-Redondo I, Soriano-Cano A, Alvarez-Bueno C, Cunha PG, Martinez-Hortelano JA, Garrido-Miguel M, et al. Skin autofluorescence-indicated advanced glycation end products as predictors of cardiovascular and all-cause mortality in high-risk subjects: a systematic review and meta-analysis. J Am Heart Assoc. 2018. https://doi.org/10.1161/JAHA.118.009833.
van Waateringe RP, Fokkens BT, Slagter SN, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, et al. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population. Diabetologia. 2019;62(2):269–80.
Kunimoto M, Yokoyama M, Shimada K, Matsubara T, Aikawa T, Ouchi S, et al. Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation. Cardiovasc Diabetol. 2021;20(1):208.
Yoshioka K. Skin autofluorescence is a noninvasive surrogate marker for diabetic microvascular complications and carotid intima-media thickness in japanese patients with type 2 diabetes: a cross-sectional study. Diabetes Ther. 2018;9(1):75–85.
Watfa G, Soulis G, Tartagni E, Kearney-Schwartz A, Borghi C, Salvi P, et al. Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations. Diabetes Metab. 2012;38(5):413–9.
Hanssen N, Engelen L, Ferreira I, Scheijen J, Huijberts M, van Greevenbroek M, et al. Plasma advanced glycation end products are not associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. Diabetologia. 2012;55:S61.
Gelzinsky J, Mayer O Jr, Seidlerova J, Materankova M, Mares S, Kordikova V, et al. Serum biomarkers, skin autofluorescence and other methods. Which parameter better illustrates the relationship between advanced glycation end products and arterial stiffness in the general population? Hypertens Res. 2021;44(5):518–27.
Kilhovd BK, Juutilainen A, Lehto S, Ronnemaa T, Torjesen PA, Birkeland KI, et al. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men—a population-based 18-year follow-up study. Arterioscl Throm Vas. 2005;25(4):815–20.
Ikram MA, Brusselle G, Ghanbari M, Goedegebure A, Ikram MK, Kavousi M, et al. Objectives, design and main findings until 2020 from the Rotterdam study. Eur J Epidemiol. 2020;35(5):483–517.
Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, et al. Simple noninvasive measurement of skin autofluorescence. Ann Ny Acad Sci. 2005;1043:290–8.
Chen J, van der Duin D, Campos-Obando N, Ikram MA, Nijsten TEC, Uitterlinden AG, et al. Serum 25-hydroxyvitamin D(3) is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: the Rotterdam study. Eur J Epidemiol. 2019;34(1):67–77.
Arsov S, Trajceska L, van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, et al. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients. Artif Organs. 2013;37(7):E114–22.
Lavielle A, Rubin S, Boyer A, Moreau K, Rajaobelina K, Combe C, et al. Skin autofluorescence in acute kidney injury. Crit Care. 2017. https://doi.org/10.1186/s13054-017-1598-0.
Du T, Brandl B, Hauner H, Skurk T. Skin autofluorescence mirrors surrogate parameters of vascular aging: an enable study. Nutrients. 2023;15(7):1597. https://doi.org/10.3390/nu15071597 .
Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam study. Eur J Epidemiol. 2012;27(3):173–85.
Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grobbee DE, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation. 2002;105(24):2872–7.
van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam study. Circulation. 2004;109(9):1089–94.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction—the Rotterdam study. Circulation. 1997;96(5):1432–7.
Vliegenthart R, Oudkerk M, Song B, van der Kuip DAM, Hofman A, Witteman JCM. Coronary calcification detected by electron-beam computed tomography and myocardial infarction—the Rotterdam coronary calcification study. Eur Heart J. 2002;23(20):1596–603.
Bos D, Leening MJG, Kavousi M, Hofman A, Franco OH, van der Lugt A, et al. Comparison of atherosclerotic calcification in major vessel beds on the risk of all-cause and cause-specific mortality the Rotterdam study. Circ-Cardiovasc Imag. 2015. https://doi.org/10.1161/CIRCIMAGING.115.003843.
Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49(3):378–402.
Mattace-Raso FUS, van der Cammen TJM, Hofman A, van Popele NM, Bos ML, Schalekamp MADH, et al. Arterial stiffness and risk of coronary heart disease and stroke – The Rotterdam Study. Circulation. 2006;113(5):657–63.
van Herpt TTW, Ligthart S, Leening MJG, van Hoek M, Lieverse AG, Ikram MA, et al. Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria. BMJ Open Diabetes Res Care. 2020;8(2):e001529.
Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.
Hangai M, Takebe N, Honma H, Sasaki A, Chida A, Nakano R, et al. Association of advanced glycation end products with coronary artery calcification in Japanese subjects with type 2 diabetes as assessed by skin autofluorescence. J Atheroscler Thromb. 2016;23(10):1178–87.
Monnier VM, Sun WJ, Gao XY, Sell DR, Cleary PA, Lachin JM, et al. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovasc Diabetol. 2015. https://doi.org/10.1186/s12933-015-0266-4.
Saz-Lara A, Alvarez-Bueno C, Martinez-Vizcaino V, Notario-Pacheco B, Sequi-Dominguez I, Cavero-Redondo I. Are advanced glycation end products in skin associated with vascular dysfunction markers? A meta-analysis. Int J Environ Res Public Health. 2020;17(18):6936.
Birukov A, Cuadrat R, Polemiti E, Eichelmann F, Schulze MB. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study. Cardiovasc Diabetol. 2021;20(1):110.
Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K, et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest. 2008;118(1):183–94.
Stirban A, Gawlowski T, Roden M. Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol Metab. 2014;3(2):94–108.
Brüel A, Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 1996;127(2):155–65.
Rabbani N, Godfrey L, Xue MZ, Shaheen F, Geoffrion M, Milne R, et al. Glycation of LDL by methylglyoxal increases arterial atherogenicity a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes. 2011;60(7):1973–80.
Ren XM, Ren LQ, Wei Q, Shao H, Chen L, Liu NF. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovasc Diabetol. 2017. https://doi.org/10.1186/s12933-017-0531-9.
Mulder DJ, De Boer JF, Graaff R, De Vries R, Annema W, Lefrandt JD, et al. Skin autofluorescence is inversely related to hdl anti-oxidative capacity in type 2 diabetes mellitus. Atherosclerosis Supp. 2011;12(1):46.
Baumann M. Role of advanced glycation end products in hypertension and cardiovascular risk: human studies. J Am Soc Hypertens. 2012;6(6):427–35.
Botros N, Sluik D, van Waateringe RP, de Vries JHM, Geelen A, Feskens EJM. Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study. Diabetes Metab Res Rev. 2017. https://doi.org/10.1002/dmrr.2892.
Franklin SS, Wt Gustin, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart study. Circulation. 1997;96(1):308–15.
Portegies ML, Mirza SS, Verlinden VJ, Hofman A, Koudstaal PJ, Swanson SA, et al. Mid- to Late-Life trajectories of blood pressure and the risk of stroke: the Rotterdam study. Hypertension. 2016;67(6):1126–32.
van Waateringe RP, Slagter SN, van Beek AP, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, et al. Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. Diabetol Metab Syndr. 2017. https://doi.org/10.1186/s13098-017-0241-1.
Kochli S, Endes K, Trinkler M, Mondoux M, Zahner L, Hanssen H. Association of physical fitness with skin autofluorescence-derived advanced glycation end products in children. Pediatr Res. 2020;87(6):1106–11.
Gubbels Bupp MR. Sex, the aging immune system, and chronic disease. Cell Immunol. 2015;294(2):102–10.
Naessen T, Rodriguez-Macias K. Menopausal estrogen therapy counteracts normal aging effects on intima thickness, media thickness and intima/media ratio in carotid and femoral arteries—an investigation using noninvasive high-frequency ultrasound. Atherosclerosis. 2006;189(2):387–92.
Juonala M, Kahonen M, Laitinen T, Hutri-Kahonen N, Jokinen E, Taittonen L, et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. Eur Heart J. 2008;29(9):1198–206.
Sinning C, Wild PS, Echevarria FM, Wilde S, Schnabel R, Lubos E, et al. Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study). Am J Cardiol. 2011;107(12):1841–7.
Shardlow A, McIntyre NJ, Kolhe NV, Nellums LB, Fluck RJ, McIntyre CW, et al. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study. Plos Med. 2020;17(7):e1003163.
